JVM Co

JVM Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of JVM Co (054950.KQ) as of Nov 4, 2026 is 0.49. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.48 — a change of 1.74% (higher).

PEG

0.49

YoY

1.74%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of JVM Co is 2025 0.49 . PEG Ratio (Price/Earnings-to-Growth) of JVM Co was 2024 0.48 . It decreases by 1.74% higher compared to the previous year.

The JVM Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
1.71 KRW
Jan 1, 2019
2.40 KRW
Jan 1, 2020
1.33 KRW
Jan 1, 2021
1.56 KRW
Jan 1, 2022
0.88 KRW
Jan 1, 2023
0.53 KRW
Jan 1, 2024
0.48 KRW
Jan 1, 2025
0.49 KRW
The JVM Co PEG history
YEARPEGYoY
0.49+1.74%
0.48-9.02%
0.53-39.96%
0.88-43.19%
1.56+16.66%
1.33-44.45%
2.40+40.66%
1.71+40.47%
1.22-3.16%
1.25-53.00%
2.67+93.77%
1.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

PEG Ratio (Price/Earnings-to-Growth) of JVM Co is 0.49 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of JVM Co changed from 0.48 to 0.49, representing a 1.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) JVM Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — JVM Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — JVM Co